ABOS · CIK 0001576885 · operating
Acumen Pharmaceuticals, Inc. (ABOS) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the Nasdaq. With a market capitalization of $168 million, Acumen Pharmaceuticals, Inc. is a micro-cap company. The stock currently trades at $3.27, up 4.30% today, with a 52-week range of $0.85–$3.05.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-1.71 | $-1.71 | -58.3% | |
| 2023 | $-1.08 | $-1.08 | -1.9% | |
| 2022 | $-1.06 | $-1.06 | — | |
| 2021 | — | — | — |